William Slayton, MD : Research

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using…

Investigators

William Slayton, Brian Stover

Status

Accepting Candidates

Ages

N/A - 21 Years

Sexes

All

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab ozogamicin…

Investigators

William Slayton, Brian Stover

Status

Accepting Candidates

Ages

365 Days - 25 Years

Sexes

All

This partially randomized phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor…

Investigators

William Slayton, Brian Stover

Status

Accepting Candidates

Ages

N/A - N/A

Sexes

All